Adjuvant HoldingsADJUVANT HOLDINGS CO.,LTD.4929東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP

Adjuvant Holdings FY ending Mar 2020 results

Adjuvant Holdings brought in ¥4.67B in revenue.

It lost about ¥4 for every ¥100 of sales at the operating level.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Adjuvant Holdings sells, how much goes where, and how much is kept.

FY ending Mar 2020
Cost of sales
¥40
SG&A
¥64
Operating loss
¥4
Net loss
¥5

Margin funnel (derived from reported values)Gross margin 60.1% → Operating margin -3.9% → Net margin -4.9%

Sources

Show source documents (3)
  • EDINET (FSA Japan)

    有価証券報告書-第35期(2023/03/21-2024/03/20)

    ID S100TLRE2024-06-13Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第33期(令和3年3月21日-令和4年3月20日)

    ID S100PFHF2022-11-11Open
  • EDINET (FSA Japan)

    有価証券報告書-第32期(令和2年3月21日-令和3年3月20日)

    ID S100LJ8Y2021-06-17Open

Extracted from XBRL: 39 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.